Use of disulfiram, acamprosate or naltrexone

No definition available.

Endpoint definition

↥

FinnGen phenotype data

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC N07BB01|N07BB03|N07BB04

Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

ALCO_PRESCRIPTION

Extra metadata

Level in the ICD hierarchy 2

First used in FinnGen datafreeze DF2

↥

List of similar endpoints to Use of disulfiram, acamprosate or naltrexone based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

↥

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.05	3.35 [1.99, 5.62]	5.1e-6	110
15 years	0.02	3.72 [2.36, 5.86]	1.5e-8	83
5 years	0.00	3.46 [1.94, 6.16]	2.5e-5	16
1 year	-	-	-	-

↥

Index endpoint: ALCO_PRESCRIPTION – Use of disulfiram, acamprosate or naltrexone
GWS hits: 0

↥

before Use of disulfiram, acamprosate or naltrexone
after Use of disulfiram, acamprosate or naltrexone

Loading survival analyses plot

Loading survival analyses table

↥